Home

Pilot feasibility study to detect mesenchymal stem cell biomarkers of bronchopulmonary dysplasia in the tracheal aspirate fluid of preterm infants

May 8th 2018 | R.G. LaGrandeur, M. Singhal, F. Bany-Mohammed, C. Uy, R. Koeppel, F. Zaldivar, F. Haddad, A. Nalbandian, P. Donovan, D.M. Cooper, M. Aslam*

Abstract.
OBJECTIVE: This study aimed to detect novel mesenchymal stem cell peptides/biomarkers of bronchopulmonary dysplasia (BPD) in the tracheal aspirate fluid (TAF) of preterm infants.

Reviews

The influence of the built environment on adverse birth outcomes

Research

Pilot feasibility study to detect mesenchymal stem cell biomarkers of bronchopulmonary dysplasia in the tracheal aspirate fluid of preterm infants

Effect of standardized feeding protocol on nutrient supply and postnatal growth of preterm infants: A prospective study

Subscribe to Front page feed